tert-Butyl 5-amino-7-oxa-2-azaspiro[3.5]nonane-2-carboxylate

Catalog No. :
ACDCWQ984
CAS No. :
1357354-13-2
Molecular Formula :
C12H22N2O3
Molecular Weight :
242.32

IUPAC Name:tert-butyl 5-amino-7-oxa-2-azaspiro[3.5]nonane-2-carboxylate

tert-Butyl 5-amino-7-oxa-2-azaspiro[3.5]nonane-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$336.00Login to see priceInquiryInquiry
250mg95%$811.00Login to see priceInquiryInquiry
1g95%$2029.00Login to see priceInquiryInquiry
5g95%$4031.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 5-amino-7-oxa-2-azaspiro[3.5]nonane-2-carboxylate
IUPAC Nametert-butyl 5-amino-7-oxa-2-azaspiro[3.5]nonane-2-carboxylate
MDL No.MFCD22209475
Molecular FormulaC12H22N2O3
Molecular Weight242.32
SMILESO=C(N1CC2(C(N)COCC2)C1)OC(C)(C)C
InChI KeyGNQAATURSWLECH-UHFFFAOYSA-N
Synonym5-Amino-7-Oxa-2-Aza-Spiro[3.5]Nonane-2-Carboxylic Acid Tert-Butyl Ester;5-Amino-7-Oxa-2-Aza-Spiro[3.5]Nonane-2-Carboxylic Acid Tert-Butyl Ester(WX100917);tert-butyl 5-amino-7-oxa-2-azaspiro[3.5]nonane-2-carboxylate;7-Oxa-2-azaspiro[3.5]nonane-2-carboxylic acid, 5-amino-, 1,1-dimethylethyl ester
CAS No.1357354-13-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACDCWQ984 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDCWQ984 route product structure diagram
    ACDCWQ9841357354-13-2
Inquiry

2. ACDCWQ984 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDCWQ984 route product structure diagram
    ACDCWQ9841357354-13-2
Inquiry

Comments (0)